5-Lipoxygenase activating protein (ALOX5AP): association with cardiovascular infarction and stroke.
Ben-Asher
Edna
E
Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel. edna.ben-asher@weizmann.ac.il
Lancet
Doron
D
D058927:5-Lipoxygenase-Activating Proteins; D002352:Carrier Proteins / Q000235:genetics*; D006801:Humans; D020024:Leukotriene Antagonists / Q000627:therapeutic use*; D015289:Leukotrienes / Q000096:biosynthesis* / Q000502:physiology; D008565:Membrane Proteins / Q000235:genetics*; D009203:Myocardial Infarction / Q000235:genetics*; D020521:Stroke / Q000235:genetics*
D058927:5-Lipoxygenase-Activating Proteins; C548592:ALOX5AP protein, human; D002352:Carrier Proteins; D020024:Leukotriene Antagonists; D015289:Leukotrienes; D008565:Membrane Proteins